antidepressant, entheogens, health medical pharma, legal status of psilocybin mushrooms, major depressive disorder, management of depression, placebo, psilocybin, psilocybin mushroom, psilocybin therapy, Tech Industry, Tech News, treatment resistant depression
Phase II Study Finds That Psilocybin Plus Therapy Can Help Treat Depression Symptoms
New research out this week is the latest to show that psilocybin—the active ingredient in magic mushrooms—can be a viable treatment for depression. The randomized Phase II trial found that a single dose of psilocybin combined with therapy significantly…
